Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I

World Journal of Surgery

Volumn 17, Issue 4, 1993, Pages 481-488

  Pipeleers Marichal, Miriam ^a,b   Donow, Christian ^a,b   Heitz, Philipp U ^a,b   Klöppel, Günter ^a,b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURGERY; CLINICAL FEATURE; CONFERENCE PAPER; GASTRINOMA; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; LAPAROTOMY; LIVER METASTASIS; LYMPH NODE METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; TUMOR LOCALIZATION; TUMOR VOLUME; ZOLLINGER ELLISON SYNDROME;

DUODENAL NEOPLASMS; GASTRINOMA; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; PANCREATIC NEOPLASMS; ZOLLINGER-ELLISON SYNDROME;

EID: 0027316922     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/BF01655107     Document Type: Article

References (84)

1. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas
2. Massive islet cell tumor of pancreas without hypoglycemia
3. Islet cell adenoma without hypoglycemia causing duodenal obstruction
4. Collective review: hyperinsulinism and islet cell tumors of pancreas with 398 recorded tumors
5. Peptic ulceration of third part of duodenum associated with islet cell tumors
6. Extraction of a gastrin-like substance from a pancreatic tumor in a case of Zollinger-Ellison syndrome
7. Zollinger-Ellison syndrome
8. Ulcerogenic tumors of the duodenum
9. The Zollinger-Ellison syndrome due to an infiltrating tumour of the stomach
10. Serum calcium, serum gastrin, and gastric acid secretion before and after parathyroidectomy for hyperparathyroidism
11. Zollinger-Ellison syndrome associated with ovarian mucinous cystadenocarcinoma
12. Ectopic apudocarcinomas and associated endocrine hyperplasias of the foregut
13. Conservative management of the Zollinger-Ellison syndrome: ectopic gastrin production by an ovarian cystadenoma
14. Pathology of the Zollinger-Ellison syndrome
15. Zollinger-Ellison syndrome due to a gastrinproducing ovarian cystadenocarcinoma
16. Extrapancreatic, extraintestinal gastrinoma: effective treatment by surgery
17. Extrapancreatic gastrinomas
18. Ectopic gastrinoma and Zollinger-Ellison syndrome
19. Zollinger-Ellison syndrome associated with a renal gastrinoma in a child
20. Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome
21. Zollinger-Ellison syndrome: cure by surgical resection of ajejunal gastrinoma containing growth hormone releasing factor
22. Gastrin-producing ovarian cystadenocarcinoma: sensitivity to secretin and SMS 201-995
23. Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome
24. Zollinger-Ellison syndrome: current concepts and management
25. The role of surgery in the Zollinger-Ellison syndrome
26. Current approach to the management of tumoral process in patients with gastrinoma
27. Localization and resection of gastrinomas in Zollinger-Ellison syndrome
28. Gastrinoma excision for cure: a prospective analysis
29. Gastrinomas: A 42-year experience
30. Source of plasma chromogranin A elevation in gastrinoma patients
31. Gastrinomas in MEN-1 [letter to the editor]
32. Surgical pathology of gastrinoma: site, size, multicentricity, association with multiple endocrine neoplasia type I and malignancy
33. Genetic aspects of adenomatosis of endocrine glands
34. Gastrinoma
35. Prevalence of endocrine abnormalities in patients with the Zollinger-Ellison syndrome and in their families
36. Familial multiple endocrine adenoma-peptic ulcer complex
37. Pancreatic polypeptide as screening marker for pancreatic polypeptide apudomas in multiple endocrinopathies
38. Peptide hormone markers in screening for endocrine tumors in multiple endocrine adenomatosis type I
39. MEN-1 pancreas: a histological and immunohistochemical study
40. Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type-I: An immunocytochemical study of nine patients
41. Resection of gastrinomas
42. Medical and surgical options in the management of patients with gastrinoma
43. Percutaneous transhepatic venous sampling of gastrin: value in sporadic and familial islet-cell tumors and G-cell hyperfunction
44. Thirty years' experience with gastrinoma
45. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type I and the Zollinger-Ellison syndrome
46. Cas cliniques: syndrome de Zollinger-Ellison avec tumeur endocrine carcinoïde insulaire de siège vésiculaire primitif
47. Zollinger-Ellison syndrome associated with pancreatic cystadenocarcinoma [letter to the editor]
48. The gastrinoma triangle: operative implications
49. Microgastrinomas of the duodenum: a cause of failed operations of the Zollinger-Ellison syndrome
50. Surgical consideration in the management of ulcerogenic tumors of the pancreas and duodenum
51. Carcinoid-islet cell tumors of the duodenum: report of twenty-one cases
52. Duodenal and ampullary carcinoid tumors: a report of 12 cases with pathological characteristics, polypeptide content and relation to the MEN-I syndrome and von Recklinghausen's disease (neurofibromatosis)
53. Outcome of lymph node involvement in patients with the Zollinger-Ellison syndrome
54. Detection of duodenal gastrinomas by operative endoscopic transillumination: a prospective study
55. Zollinger-Ellison syndrome: a new look at regression of gastrinomas
56. The influence of total gastrectomy on survival in malignant Zollinger-Ellison tumors
57. Treatment of the Zollinger-Ellison syndrome: a 25 year assessment
58. Extrapancreatic gastrinoma with pancreatic islet cell hyperplasia
59. Controversies in the management of Zollinger-Ellison syndrome
60. Removal of gastrinomas for control of Zollinger-Ellison syndrome
61. Favourable response to conservative surgery for extra-pancreatic gastrinoma with lymph node metastases
62. The surgical treatment of gastrinoma in MEN-I syndrome patients
63. Are “aberrant nodal gastrinomas” pathogenetically similar to “lateral aberrant thyroid” nodules?
64. Concomitance of multiple adenomas of the parathyroids and pancreatic islets with tumor of the pituitary: a syndrome with familial incidence
65. Zollinger-Ellison syndrome (gastrinoma): current diagnosis and treatment
66. The management of Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type I
67. Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study
68. Pancreatic venous sampling and arteriography in localizing insulinomas and gastrinomas: procedure and results in 55 cases
69. Intraoperative ultrasonographic localization of islet cell tumors: a prospective comparison to palpation
70. Duodenal wall tumors and the Zollinger-Ellison syndrome
71. Endocrine tumors of the pancreas
72. Zollinger-Ellison syndrome: current concepts in diagnosis and management
73. Characteristics of duodenal wall gastrinomas
74. Benign and malignant gastrinoma
75. Multiple endocrine syndrome type I: clinical, laboratory findings, and management in five families
76. Antro-Pyloric gastrinoma associated with pancreatic nesidioblastosis and proliferation of islets
77. Pathomorphologic, biochemical and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome)
78. Two distinct types of islet abnormalities associated with endocrine pancreatic tumours
79. Nesidioblastosis and islet cell changes related to endogenous hypergastrinemia
80. Morphometry of the pancreatic islets in patients with insulinomas and gastrinomas
81. Carcinoid (ECL cell) tumour of the oxyntic mucosa of the stomach: a hormonedependent neoplasm?
82. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type I multiple endocrine neoplasia
83. Multiple hormone elevations in Zollinger-Ellison syndrome
84. Microwave technology in immunohistochemistry: application to avidin-biotin staining of diverse antigens